(YGd)/sub 3/Co/sub 5/O/sub 12/IG
Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... For these MFs, the hydrodynamic diameters of MNPs, as well as the MNPs with anti-AFP and anti-CEA coating, are 57.3 ± 15.2 nm, 54.3 ± 10.1 nm, and 54.4.0 ± 10.5 nm, respec- tively (Figure 2A). The measured saturation ...
10
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... and 12 h light/dark cycle) and had free access to water and ...Fe 3 O 4 -PLGA or Fe 3 O 4 -PLGA-cRGD NPs at a final dosage of 1 mg lyophilized powder dissolving 1 mL phosphate- buffered ...
14
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... MNPs-Fe 3 O 4 , or the copolymer of ART with MNPs- Fe 3 O 4 in the presence or absence of 40 µ M Z-VAD-FMK for 48 ...L, 5 mg/mL) was added to each well and incubated for 4 ...
8
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... Fe 3 O 4 was washed twice with distilled water, dried, and suspended using normal saline (final concentration ...for 5 minutes at 2500 rpm; the supernatant was then removed and OD values were ...
10
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... for 5 minutes and dried in ...in 5 mL ...in 3% bovine serum albumin and phosphate-buffered solution at 37 ° C for one hour to block excess active groups and nonspecific binding sites on the ...
11
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... different pH levels which are similar to the pH of the stomach and the pH of the blood. Generally, the pH of the stomach varies from 1–2 to 4–5. After eating, the stomach releases proteases and hydrochloric acid ...
12
Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
... MNP-Fe 3 O 4 , adriamycin + MNP-Fe 3 O 4 , daunorubicin + MNP-Fe 3 O 4 , dexamethasone + MNP-Fe 3 O 4 , and RPMI 1640 alone were added to these cells and cultured ...
6
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... suspension was placed in a 96-well microtiter plate in 200 µ L aliquots, and cultured in the presence or absence of T-cell mitogen (concanavalin A [ConA], Sigma, USA) (5 µ g/mL). Meanwhile the wells receiving ...
7
<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>
... does not apply to the controlled and proper administration of medical ozone. 12 Ozone therapy is based on high doses in order to stimulate the immunology system. Numerous studies have proven that ozone therapy ...
16
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... Notes: (A) cell viability of l929 cells incubated with different concentrations (10 µM, 1 µM, and 100 nM) of the gd-NPs for 24 and 48 hours. (B) apoptosis rates of Raw264.7 cells were measured by flow cytometry at 48 ...
11
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... In order to examine the expression of caspase-3, bax, bcl-2, NF- κ B, and survivin, we next performed Western blot analysis on whole cell protein extracted from cells treated for 48 hours as described previously. ...
9
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... After intragastric administration, 0.2–0.5 mL of blood from one mouse in each group were collected into an ethylene- diaminetetraacetic acid tube by enucleating eyeballs at the time points of zero minutes, hours 1, ...
6
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... (FeCl 3 ⋅ 6H 2 O), ferrous chloride tetrahydrate (FeCl 2 ⋅ 4H 2 O), and ammonium hydroxide (25 wt%) were purchased from Fluka (Buchs, ...for 12 hours and used without further ...
16
Effect of Alkaline and Alkaline Earth Metal Oxides Addition on the Glass Formation and Crystallization of ZnO Al<sub>2</sub>O<sub>3</sub> SiO<sub>2</sub> Glasses
... Transparent glass-ceramics are attractive materials as optical advices because they have both the good formability of glasses and excellent optical properties of crystals. The size of crystals in transparent glass- ...
13
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... Chemical Co, St. Louis, MO) for 68 hours at 37 ° C in a 5% humidified CO 2 ...L 3-2 (4, 5-dimethylthiazol-2-yl) 2, 5-diphe- nyltetrazolium bromide (MTT) ...
6
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... Fe 3 O 4 -MNP increased to ...Fe 3 O 4 -MNP- DNR-5-BrTet the temperature increased to ...Fe 3 O 4 -MNP throughout the ...Fe 3 O 4 -MNP or Fe 3 ...
9
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... MgNPs-Fe 3 O 4 (1 µ g/mL, 10 µ g/mL, or 100 µ g/mL) for 24 hours in the absence or presence of N-acetylcysteine (NAC; 10 mM) (Sigma-Aldrich Co); NAC was added 3 hours before treatment with ...
10
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... with 5 mg EDC and 5 mg NHS for 30 minutes at room ...with 5 mg PLGA, then intermittently sonicated for 30 minutes at room ...with 5 mg EDC, 5 mg NHS, and 500 µ L DOX (2 ...for 3 ...
9
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... (Sigma-Aldrich Co.), ascorbic acid (C 6 H 8 O 6 ; Sigma-Aldrich ...(NaHCO 3 ; Sigma-Aldrich ...Sigma-Aldrich Co.], sodium chloride [NaCl; Sigma-Aldrich Co.]), and ...
12
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... This experimental protocol was in accordance with the principles of the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the ethical and research committee of Xiamen ...
16